Chair: Welcome back to the Reconvened 67th Session. We will continue the consideration on Item 4 on strategic management, budgetary and administrative questions. At our joint meeting with the CCPCJ yesterday, we considered under Agenda Item 4 the implementation of the consolidated for the biennium 2024-2025 for the UNODC. And the drugs proposed program plan …
India
CND Chair’s Special Event – Evidence to Impact: Powering Effective Drug Policy with Data Collection and Research
Event to commemorate the International Day against Drug Abuse and Illicit Trafficking and to launch the 2024 UNODC World Drug Report Event Information Page Chair: this day serves as a strong reminder for the need for collective action. We unite to explore evidence-based approaches that empower us to address the WDP head on. Data collection …
Item 5. Implementation of the international drug control treaties (Tuesday morning)
Chair: We will consider scheduling recommendations by WHO and INCB. CND Secretariat: Recalls the substances and scheduling recommendations. Chair: Explains process to schedule substances under 1961, 1971 and 1988 conventions. Butonitazene WHO: Butonitazene, or butoxynitazene, is a benzimidazole-derived synthetic opioid not currently under international control and lacking recognized therapeutic use. It appears as a crystalline …
Item 5. Implementation of the international drug control treaties (Monday morning)
Item 5b UNODC, Drugs, Laboratory and Scientific Services Branch (DLSSB): Thank you, Mr. Chair. distinguished delegates, ladies and gentlemen, as you’re well aware that new psychoactive substances are not under international control, but they produce the same harmful effects as the ones we have under control. In just over a decade, the number of these …
Item 3. High-level segment (Friday evening)
India: India acknowledges the challenges and affirms its commitment to fight the global drug menace. Our diversity and federal structure recognises that drug control requires a multi-agency coordination. India has a strong commitment to the guiding principles of the three drug control conventions, the ECOSOC and the General Assembly. We maintain a zero tolerance policy …
Round Table 2 – The Way Forward: The Road to 2029
Germany/Chair: Hello, welcome to our discussion regarding the way forward in advancing the implementation of all international drug policy commitments in light of the 2029 finally view of certain 2019 Ministerial Declaration in accordance with CND Resolution 66 Adopted by the Commission last March, this roundtable will consist of panel interventions followed by an interactive …